leisure time -WSS

leisure time

author：explore 2025-10-02 00:29:09 - browse：91

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： How medical schools plan to diversify without affirmative action

hotspot

WSS

Walmart eyes Medicare Advantage provider ChenMed

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Why Sanofi got shellacked over its spinoff

Emergency medicine has repudiated 'excited delirium.' Now what?

IRA could hurt research into orphan drugs for rare diseases

Food makers to regulators: Ultra

hotspot

leisure time

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Medtronic CEO on promising devices for diabetes, hypertension

Dobbs anniversary: the lost opportunity of abortion as health care

What to make of Biden’s latest efforts on cancer research

Affirmative action in medical school literally saved lives

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Guidelines to prevent youth baseball injuries need more muscle

Acelyrin, a rare IPO success, stumbles in its first big test

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA panel endorses Alnylam’s heart drug — after picking it apart

explore

What to make of Biden’s latest efforts on cancer research

New Covid vaccine is recommended for everyone 6 months or older

Telehealth for opioid use disorder is lifesaving

Acelyrin, a rare IPO success, stumbles in its first big test

Eli Lilly to pay $200M for Beam’s stake in gene

Biden's order seeks to regulate AI risk without stifling innovation

focus

hotspot

hotspot

focus